Clinical Trials Directory

Trials / Completed

CompletedNCT04480775

Triamcinolone Versus Methylprednisolone in Transversus Abdominis Plane Block

Triamcinolone Versus Methylprednisolone in Ultrasound Guided Transversus Abdominis Plane Block in Major Open Abdominal Surgery

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
84 (actual)
Sponsor
ghada fouad · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

In the current Study we will compare between triamcinolone and methylprednisolone as an additive to bupivacaine drug in ultrasound guided TAP block in major open abdominal surgery .

Detailed description

Postoperative pain is one of the main causes of respiratory function derangement after abdominal surgery .Transversus abdominis plane (TAP) block is widely used in abdominal surgery for postoperative analgesia The transversus abdominis plane (TAP) block is aperipheral nerve block that involves the injection of alocal anesthetic (LA) in the plane between the internaloblique and transversus abdominis muscle layers, with the aim of anesthetizing the intercostal nerves supplyingthe abdominal wall (from T6 to L1) By blocking intercostal nerves T6 to L1, TAPblock efficiently blocks somatic pain after abdominalwall surgery . It providesadequate postoperative pain relief following various abdominal surgeries TAP block can reduce pain scores, opioid consumption, and the incidence of opioid-related complications after abdominal surgery. The duration of the TAP block is limited to theeffect of the administered LAs. Various adjuvantmedications have been added to the LA to prolong theduration of TAP block and magnify its effects . Perineural injection of steroids is reported to influence postoperative analgesia. As a synthetic glucocorticoid, triamcinolone acetonide binds to and activates the glucocorticoid receptor to produce anti-inflammatory responses,such as down-regulating pro-inflammatory cytokine expression , preventing prostaglandin and leukotriene synthesis and release of arachidonic acid, and activating anti-inflammatory transcription factors such as lipocortins

Conditions

Interventions

TypeNameDescription
DRUGTriamcinolonetransversus abdominis plane block with bupivacain and triamicinolone
DRUGMethylprednisolonetransversus abdominis plane block with bupivacaine and methylprednisolone
DRUGbupivacainetransversus abdominis plane block with bupivacaine alone

Timeline

Start date
2020-07-15
Primary completion
2020-12-15
Completion
2020-12-15
First posted
2020-07-21
Last updated
2021-03-03

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04480775. Inclusion in this directory is not an endorsement.